Kazia says glioblastoma trial data won’t support FDA accelerated nod for lead drug
[ad_1]
Kazia says glioblastoma trial data won’t support FDA accelerated nod for lead drug
[ad_2]
Similar Posts
Yellen: COVID stimulus may have contributed a little bit to higher inflation
Byadmin
[ad_1] Yellen: COVID stimulus may have contributed a little bit to higher inflation [ad_2]
LiveOne reaches 450K+ subscribers through Tesla partnership
Byadmin
[ad_1] LiveOne reaches 450K+ subscribers through Tesla partnership [ad_2]
Sage sues Biogen in wake of $469M buyout offer: report
Byadmin
[ad_1] Sage sues Biogen in wake of $469M buyout offer: report [ad_2]
Biggest stock movers Friday: MVST, RKLB, and more
Byadmin
[ad_1] Biggest stock movers Friday: MVST, RKLB, and more [ad_2]
Top dividend picks for 2025 according to Seeking Alpha’s Quant metrics
Byadmin
[ad_1] Dec. 26, 2024 1:26 PM ETEIX, DVY, AMGN, QCOM, SDY, LMT, CI, PAYX, VIG, TROW, SNA, VYM, PM, DGRO, HDV, SCHD, NOBL, SPYD, VYMI, VIGI, VICI, SDVYBy: Jason Capul, SA News Editor Daniel Grizelj As traders and investors turn their focus to 2025, one area poised to attract significant attention is the dividend sector,…
IPO Roundup: Cre8 Enterprise, Diginex and more
Byadmin
[ad_1] IPO Roundup: Cre8 Enterprise, Diginex and more [ad_2]